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Retinitis pigmentosa (RP) refers to a genetically heterogeneous group of progressive neurodegenerative diseases that result in dysfunc-
tion and/or death of rod and cone photoreceptors in the retina. So far, 18 genes have been identiﬁed for autosomal-dominant (ad) RP.
Here, we describe an adRP locus (RP42) at chromosome 7p15 through linkage analysis in a six-generation Scandinavian family and iden-
tify a disease-causing mutation, c.449G/A (p.S150N), in exon 6 of the KLHL7 gene. Mutation screening of KLHL7 in 502 retinopathy
probands has revealed three different missense mutations in six independent families. KLHL7 is widely expressed, including expression
in rod photoreceptors, and encodes a 75 kDa protein of the BTB-Kelch subfamily within the BTB superfamily. BTB-Kelch proteins have
been implicated in ubiquitination through Cullin E3 ligases. Notably, all three putative disease-causing KLHL7 mutations are within
a conserved BACK domain; homology modeling suggests that mutant amino acid side chains can potentially ﬁll the cleft between
two helices, thereby affecting the ubiquitination complexes. Mutations in an identical region of another BTB-Kelch protein, gigaxonin,
have previously been associated with giant axonal neuropathy. Our studies suggest an additional role of the ubiquitin-proteasome
protein-degradation pathway in maintaining neuronal health and in disease.Introduction
Retinal diseases are a major cause of inherited irrevers-
ible vision loss worldwide. Retinitis pigmentosa (RP
[MIM 268000]) refers to a clinically diverse group of
retinal degenerative diseases that are characterized by
night blindness, bone spicule-like pigmentation, and
progressive constriction of visual ﬁelds.1 Degeneration
of rod and cone photoreceptors constitutes the major
pathological manifestation of RP, which may be in-
herited in an autosomal-dominant (ad), autosomal-
recessive, or X-linked manner.1,2 To date, 192 retinal
disease loci have been mapped and 144 genes identiﬁed
(see RetNet website). Mutations in at least 60 genes may
cause RP; of these, 18 genes have been associated with
ad forms of RP. Screening of the 18 disease genes has
led to detection of mutations in 50%–60% of adRP fami-
lies; thus, genetic defects in many patients are yet to be
identiﬁed.3
The adRP genes encode an array of proteins involved
in diverse biological functions, including phototransduc-
tion, gene regulation, splicing, and photoreceptor outer792 The American Journal of Human Genetics 84, 792–800, June 12segment morphogenesis.1,2 Notably, a vast majority of
adRP proteins are widely expressed, yet most genetic
defects speciﬁcally lead to photoreceptor degeneration.
Multiple causes of photoreceptor dysfunction or death
have been proposed. These include improper levels of
cyclic nucleotides, calcium ion inﬂux, and oxidative
stress.4 However, the molecular etiology and biochemical
mechanism(s) of most forms of adRP still remain to be
elucidated.
We describe here the mapping of an adRP locus
(RP42) by whole-genome scan of a large Scandinavian
family and identify the disease-causing mutation in
a BTB-Kelch protein, KLHL7 (MIM 611119). Additional
screening of 502 retinopathy patients from North Amer-
ica and Europe has revealed a total of three missense
mutations in KLHL7 in six families. The three mutations
appear to affect the predicted KLHL7 protein structure,
as indicated by in silico homology modeling. On the
basis of the presence of BTB and Kelch domains, we
suggest that KLHL7 participates as an adaptor and/or
chaperone in the ubiquitin-proteasome protein-degrada-
tion pathway.1Neurobiology-Neurodegeneration & Repair Laboratory (N-NRL), National Eye Institute, National Institutes of Health (NIH), Bethesda, MD 20892, USA;
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Subjects and Methods
Genotyping and Linkage Analysis
Human studies were approved by their respective institutional
review boards and performed in accordance with the Declaration
of Helsinki. DNA samples from 23 individuals of Scandinavian
adRP family 72 were hybridized to Affymetrix SNP Nsp 250K array
according to the manufacturer’s recommendations (Affymetrix,
Santa Clara, CA, USA). After scanning, the CEL ﬁles were analyzed
with the BRLMM Analysis Tool 1.0 (Affymetrix). The resulting
brlmm ﬁle was imported into Alohomora5 and analyzed with
GRR6 and Pedstats7 for a check of the integrity of the pedigree
and selection of uninformative and/or mistyped SNPs for removal
from the data set. SNPs were subsequently exported into Mega28
and reformatted as individual chromosomes for linkage in
Merlin.9 Multipoint linkage analysis was performed with a para-
metric model assuming an ad mode of inheritance, a disease-allele
frequency of 0.0001, and 100% penetrance.
Human-Mutation Screen
We carried out a mutation screen of KLHL7 in patients or controls
collected fromNorth America (Michigan and Texas cohorts), Scan-
dinavia, and the UK. The North American retinopathy cohort
collected in Michigan has been previously described.10 Of the
282 patients screened in this cohort, 170 have RP and nine are
known to have adRP. PCR primer sets are listed in Table S1 (avail-
able online). PCR ampliﬁed DNA was sequenced using ABI 3130xl
Genetic Analyzer (Applied BioSystems, Foster City, CA).
RT-PCR
RNA samples from mouse tissues and ﬂow sorted GFP-tagged
photoreceptors were used as templates for RT-PCR. The KLHL7
PCR primers spanned an intron. The primers are listed in Table S2.
Immunoblot Analysis
Procedures withmice were followed in accordance with the ethical
standards of the National Eye Institute (NEI) Animal Care and Use
Committee at NIH. Retinas from C57BL/6J mice were sonicated
in PBS and 3X protease inhibitor cocktail (Roche, Indianapolis,
IN,USA) and centrifuged at 16,0003 g for 5min at 4C. Theprotein
extract was analyzed with NuPAGE 10% bis-Tris gel (Invitrogen,
Carlsbad, CA, USA). Proteins were transferred to Hybond
membrane (Amersham Biosciences, Piscataway, NJ, USA) in
NuPAGE transfer buffer (Invitrogen). The membrane was preincu-
bated in 5% nonfat milk in TBS with 0.1% Tween 20 (TBST) for
1 hr at room temperature and then incubated with a mouse
a-KLHL7 polyclonal antibody (Abnova, Walnut, CA, USA; 1:2000,
stored in 50% glycerol) overnight at 4C. After washing, the blot
was incubated with a donkey a-mouse HRP (Jackson Immunore-
search, West Grove, PA, USA; 1:4000) secondary antibody in 5%
TBST, washed again, and visualized via chemiluminescence (Ther-
moscientiﬁc, Rockford, IL, USA).
Immunostaining
Cryosectioned slides of C57BL/6J mouse retinas (10 mm) were pre-
incubated with 5% BSA diluted in PBS containing 0.2% Tween 20
(PBST) for 30 min at room temperature. Sections were then incu-
bated with a mouse a-KLHL7 polyclonal antibody (Abnova;
1:400), in 2% BSA diluted in PBST, overnight at 4C in a humidity
chamber. After three rinsings with PBST, sections were incubated
with a goat a-mouse Alexaﬂuor 488 secondary antibody (Invitro-The Amgen; 1:1000), in 2% BSA diluted in PBST, for 30 min at room
temperature in a humidiﬁcation chamber. Sections were then
stained with DAPI (Invitrogen; 1:1000) for 2 min, rinsed three
times with PBST, and mounted with gel mount (Electron Micros-
copy Sciences, Hatﬁeld, PA, USA). Confocal microscopy of immu-
nostained sections was carried out on a Leica confocal microscope.
Leica software was used for imaging and analysis.
Retinas from the adult Nrl-p-GFP mice11 were dissected in
DMEM medium (Invitrogen), cut into small pieces, and dissoci-
ated by continuous mixing in DMEMmedium, containing Papain
at a concentration of 8.5 U per mL (Sigma, St. Louis, MO, USA) and
0.29 mM L-cysteine (Sigma), at 37C for 15 min. Dissociated cells
(including photoreceptors) were ﬁxed for 10 min at room temper-
ature, then for 20 min at 37C in 4% paraformaldehyde in PBS.
Immunostaining was carried out as described above.
Protein Structure Modeling and Residue Permutation
Homology modeling was accomplished with the use of SWISS-
MODEL in automated mode.12–15 The protein sequence used
(NP_001026880.2) was obtained via NCBI-Entrez. Residue permu-
tation was carried out with WHAT IF.16 Energy minimization,
superposition, and root-mean-square deviation (RMSD) calcula-
tions were performed in DeepView (v4.0.1). Finished structures
were rendered in POV-Ray.
Results
Mapping of a New adRP Locus RP42 to Chromosome
7p15
We have been studying a large six-generation Scandina-
vian family (family 72)17 afﬂicted with a slow progressing
retinopathy (Figure 1A). The retinal fundus image and
full-ﬁeld electroretinogram (ERG) of the proband V.8
(Figures 1B and 1C) demonstrate a late-onset RP with
mild and slower than usual progression of disease. Similar
ﬁndings were observed in other family members, though
some had a more aggressive form of retinal degeneration.
Given that analysis of polymorphic markers excluded the
involvement of previously mapped adRP loci (data not
shown), we undertook a whole-genome scan of 23 individ-
uals in family 72 with the use of Affymetrix Nsp 250K SNP
chips. Linkage analysis of genotyping data via Merlin9
revealed a multipoint peak LOD score of 5.0 on chromo-
some 7p15 for this adRP locus (called RP42) (Figure 1D).
The results of the whole-genome linkage scan are shown
in Figure S1.
Identiﬁcation of a Missense Mutation in KLHL7
Evaluation of haplotypes in family 72 determined
an approximately 3 Mb critical region, ﬂanked by
markers SNP_A-4196981 (rs4719697) and SNP_A-1989250
(rs2188993). This critical region included 30 annotated or
predicted genes (Figures 1E and 1F). The RP42 locus is
distinct from the previously reported RP9 locus (MIM
607331), which is ﬂanked by markers D7S526 and
D7S484.18 An ad cystoid macular dystrophy locus
(CYMD [MIM 153880]), previously mapped to a 20 cM
region ﬂanked by markers D7S493 and D7S526,19 overlapserican Journal of Human Genetics 84, 792–800, June 12, 2009 793
Figure 1. Linkage Analysis and Genetic Screen of Family 72
(A) Pedigree of family 72. Individuals genotyped for linkage are noted by number symbols. Individuals sequenced in exon 6 of KLHL7 are
noted with an asterisk.794 The American Journal of Human Genetics 84, 792–800, June 12, 2009
with the RP42 locus. We performed mutation screens of
several genes within the RP42 critical interval by
sequencing predicted or known exons and corresponding
exon-intron boundary regions. No obvious disease-causing
variants were detected in NUPL2, GPNMB (MIM 604368),
C7ORF30, IGF2BP3 (MIM 608259), NPY (MIM 162640),
MPP6 (MIM 606959), DFNA5 (MIM 608798), OSBPL3
(MIM 606732), or NPVF. We subsequently discovered
a nonsynonymous and potentially disease-causing
c.449G/A, p.S150N mutation in exon 6 of the KLHL7
gene (Figure 1G). This change segregated perfectly with
the disease in 24 family members that were examined.
Evaluation of 102, 183, and 185 unaffected control indi-
viduals from Scandinavia, North America, and the UK,
respectively, did not reveal an S150N variant.
KLHL7 Mutation Screening in Retinopathy Patients
We then screened the KLHL7 gene for possible mutations
in 502 unrelated adRP probands from Europe and North
America (Figure 2). The c.449G/A, p.S150N sequence
alteration, detected in Scandinavian family 72, was also
discovered in two affected individuals of an RP family
from North America (RFS073). Another independent puta-
tive mutation, c.458C/T, p.A153V, was observed in three
families. This variant was concordant in 11 members of
Scandinavian family 101, detected in the proband of
UK family RP9713, and identiﬁed in three affected individ-
uals of North American family RFS038 (Figure 2). A third
independent and potentially disease-causing change at
residue c.457G/A, encoding a p.A153T alteration, was
uncovered in a patient from North American family
RFS061 (Figure 2H). However, other members of this
family were unavailable for genetic analysis. Additional
genetic variants of uncertain signiﬁcance are summarized
in Table 1.
To test the likelihood that theKLHL7mutations (reported
here) cause disease, we performed an additional linkage
experiment combining families 101, RFS073, and RFS038,
grouping the mutant allele from each family as a single
marker. Our analysis generated a LOD score of 3.185, indi-
cating that the observed genotype is 1530 timesmore likely
to occur when the gene is completely linked to the trait.
This analysis further supports the likelihood thatmutations
in KLHL7 cause disease.The AmAll three missense mutations that we report here in six
independent adRP families are present in exon 6 of KLHL7
andwere not observed in 470 controls fromNorthAmerica,
Scandinavia, or the UK. Both S150 and A153 residues are
completely conserved in 12 orthologs of KLHL7 from
human to fugu. Of the 38 currently annotated human
‘‘Kelch-like’’ proteins in the NCBI database, neither amino
acid residue is completely conserved through evolution.
However, we speculate that the secondary structure of this
region of the BACK domain is conserved.
We also observed two individuals with putative disease-
causingmutations, c.763G/A(p.D255N)andc.1414A/G
(p.K472Q). Although these changeswerenot present in 166
controls, we were not able to test segregation of these alter-
ations with disease. Until functional effect of these changes
is demonstrated, we consider D255N and K472Q to be of
uncertain signiﬁcance.
Overall, on the basis of analysis of a cohort previously
used for ascertaining prevalence of adRP mutations,3 we
estimate that KLHL7 is responsible for 1%–2% of adRP.
Expression Proﬁle of KLHL7
RT-PCR analysis revealed that Klhl7 is widely expressed in
mouse tissues (Figure 3A). Immunoblot analysis of retinal
extracts with the use of a commercial a-KLHL7 antibody
showed a single, somewhat larger than predicted protein
band of 75 kDa (Figure 3B). It is therefore likely that
KLHL7 is subject to posttranslationalmodiﬁcations. Immu-
nohistochemical analysis demonstrated cytoplasmic stain-
ing with some perinuclear distribution of KLHL7 in
ganglion cell and inner nuclear layers of adultmouse retina
(Figure 3C). A pattern thatwas similar butwith lower inten-
sity was detected in photoreceptors. RT-PCR and immuno-
cytochemistry experiments of GFP-tagged rods enriched
from the retina of Nrl-GFP mice,11 together with in silico
analysis of microarray data,11 validated the expression of
KLHL7 in rod photoreceptors (Figures 3A and 3D).
Analysis of the KLHL7 Protein Structure
KLHL7 encodes two transcripts with distinct 50- exons
(Figure 1F), thereby coding for predicted protein isoforms
of 564 and 586 residues with different N-terminal regions.
(Figure 4A shows KLHL7 isoform 1 with putative muta-
tions.) Both isoforms of KLHL7 contain BTB (Bric-a-brac,(B) Fundus photograph of individual V.8. Very mild degeneration is observed.
(C) ERG traces of individual V.8 illustrate isolated rod responses to single flashes of blue light (left column), mixed responses to single
flashes of white light (middle column), and isolated cone responses to 30 Hz flickering light (right column).
(D) Linkage analysis of 23 individuals from family 72. A peak multipoint LOD score of 5.0 was obtained on chromosome 7p15.
(E) Disease-chromosome haplotypes of individuals IV.6, V.11, IV.3, IV.4, IV.2, V.8, IV.16, and V.17. Recombinations between
SNP_A-4196981 (rs4719697) and SNP_A-4197412 (rs3857716), and SNP_A-2187706 (rs7780038) and SNP_A-1989250 (rs2188993),
respectively, denote the critical region. Mb denotes Megabase.
(F) Physical map of the adRP critical region. Mb denotes Megabase. Genes completely screened for mutations are labeled. The intron-exon
structure for KLHL7 isoforms 1 and 2 are shown.
(G) Chromatogram of KLHL7 exon 6 sequences in individuals V.8 and IV.7 from family 72 are shown. Proband V.8 contains a heterozygous
G-to-A transition, c.449G/A, leading to a predicted p.S150N amino acid change. A related unaffected individual, IV.7, has a homozygous
G at the same residue.erican Journal of Human Genetics 84, 792–800, June 12, 2009 795
Figure 2. Mutation Screen of KLHL7
Individuals in pedigrees sequenced in exon 6 of KLHL7 are denoted with an asterisk. Probands are marked with an arrow. Individuals of
unknown phenotype are marked with gray.
(A) Pedigree and chromatograms of a c.449G/A-containing proband in North American family RFS073. Sequences of II.1 and II.3 are
shown.
(B) Pedigree of Scandinavian adRP family 101.
(C) Fundus photograph of individual III.3. Retinal degeneration and pigmentation are observed.
(D) ERG analysis of individual III.3. Rod and cone photoreceptor responses were moderately reduced.
(E) Chromatograms of individuals III.3 and III.11, showing the c.458C/T mutation and no change, respectively.
(F) Pedigree of UK family RP9713. Chromatogram of individual II.1, with the c.458C/T change, and an unrelated unaffected individual.
(G) Pedigree of North American adRP family RFS038. Chromatograms of individuals II.3, III.3, and III.4 reveal the c.458C/T mutation.
(H) Pedigree of North American adRP family RFS061. Chromatogram of proband III.3, showing the c.457G/A mutation.Tramtrack, and Broad Complex), BACK, and Kelch func-
tional domains, suggesting that KLHL7 is a BTB-Kelch
protein.20,21 Homology modeling of the three KLHL7
domains shows respective similarity to (1) the BTB domain
of B cell lymphoma 6 (BCL6 [PDB: 1r29A]), (2) the BACK
domain of Kbtbd4 (PDB: 2eqxA), and (3) the Kelch domain796 The American Journal of Human Genetics 84, 792–800, June 12,of KLHL12 (PDB: 2vpjA). All three mutations that we
identiﬁed are within the alpha helical secondary structure
a1 of the KLHL7 homology model, ascertained on the
basis of the solution structure of Kbtbd4 (PDB: 2eqxA)
(Figure 4B). Tertiary models of each mutation in the
KLHL7 homology model revealed only a subtle effect on2009
Table 1. A Summary of the KLHL7 Mutation Screen in Retinopathy Patients
Scandinavia adRP
Cohort
United Kingdom
adRP Cohort
University of Michigan
N.A. Retinopathy Cohort
University of Texas
N.A. adRP Cohort
Proband Control Proband Control Proband Control Proband Control DB SNP ID
Putative Disease-Causing Changes
Exon 6 c.449G/A (p.S150N) 1 0 0 0 0 0 1 N/A
Exon 6 c.457G/A (p.A153T) 0 0 0 0 0 0 1 N/A
Exon 6 c.458C/T (p.A153V) 1 0 1 0 0 0 1 N/A
Variants
50 UTR c.-235G/T N/A N/A 0 N/A 3 N/A N/A N/A
50 UTR c.-118G/A N/A N/A 0 N/A 1 N/A N/A N/A
Exon 2 c.53A/G (p.K18R, isoform 2) N/A N/A 0 N/A 4 N/A 1 N/A rs17147682
Exon 5 c.352C/T (p.L118L) N/A N/A 0.64 C,
0.36 T
N/A 0.68 C,
0.32 T
N/A 0.76 C,
0.24 T
N/A rs15775
Exon 6 c.513G/A (p.Q171Q) 0 0 0 0 1 0 0 N/A
Exon 7 c.763G/A (p.D255N) N/A N/A 0 N/A 1 0 0 N/A
Exon 8 c.816G/A (p.L272L) N/A N/A 0 N/A 0 N/A 1 N/A
Exon 9 c.1177þ77C/T N/A N/A 0.96 C,
0.04 T
N/A 0 N/A 0 N/A rs858312
Exon 10 c.1380-12T/G N/A N/A 0 N/A 0 N/A 1 N/A
Exon 10 c.1267C/T (p.H423Y) N/A N/A 0 N/A 0 N/A 1 N/A
Exon 10 c.1353T/C (p.C451C) N/A N/A 0 N/A 0 N/A 1 N/A
Exon 11 c.1414A/G (p.K472Q) N/A N/A 0 N/A 1 0 1 N/A
Exon 11 c.1440A/G (p.K480K) N/A N/A 1 N/A 0 N/E 0 N/A
Exon 12 c.1578T/C (p.V526V) N/A N/A 0 N/A 1 N/A N/A N/A
30 UTR c.*7A/G N/A N/A 0 N/A 1 N/A N/A N/A
30 UTR c.*23_35delinsTG N/A N/A 0 N/A 4 N/A N/A N/A
Patients Analyzed
37 102 96 185 282 183 (Exon 6) 87 N/A
Probands and unaffected controls were sequenced for changes in exons 1 through 12 of KLHL7. Abbreviations are as follows: RP, retinitis pigmentosa; adRP,
autosomal-dominant retinitis pigmentosa; N.A., North American; U, university; N/A, no patients sequenced; N/E, not examined; UTR, untranslated region.
Compound changes include one person with c.-235G/T and c.53A/G changes, one with c.1578T/C and c.*7A/G, two with c.53A/G and c.*23_35
delinsTG, and one with c.-235G/T, c.53A/G, and c.*23_35delinsTG. The c.1267C/T (p.H423Y) alteration was not observed as segregating with
the disease and was therefore considered a non-disease-causing variant. North American controls numbering 166 individuals were examined for exons
7 and 11.protein structure (data not shown). Examination of H
bonding showed slightly varied bond lengths within
the a1 and a2 helices of each corresponding mutant struc-
ture, including the formation of one additional H bond
between residues 150 and 165 in the mutant S150N. Local
tertiary structure inspection of a1 and a2 (Figure 4C, top
left panel) shows that the introduction of mutant side
chains appears to ﬁll the space (i.e., cleft) between the
two helices (Figure 4C, top right and lower panels).
Crystal structures of BTB-Kelch proteins are suggested to
be similar to that of the Skp1-Cdc4 complex (PDB: 1nex).20
a1 and a2 helices in the KLHL7 BACK-domain structure
(based on PDB: 2eqxA) appear highly structurally similar
(root mean square deviation [RMSD] ¼ 0.84A˚) to the
C-terminal a5 and a6 helices of Skp1 (see PDB: 1nex)
(Figure 4D, inset). Introduction of the three KLHL7 muta-
tions did not show any gross structural effects. Notably,
however, Skp1 and F box (see PDB: 1nex) proteins were
suggested to associate by an ‘‘interdigitation of helices’’
that include Skp1 a5 and a6, giving rise to a ‘‘contiguous
hydrophobic core’’ spanning the two proteins (Skp1 andThe AmF box).22 We hypothesize that the side-chain space ﬁlling
between a1 and a2, caused by KLHL7 mutations (S150N,
A153V, and A153T), affects this ‘‘core’’ and the interaction
or function of other domains of KLHL7 within the context
of the overall protein.
Discussion
Retinal photoreceptors are highly metabolically active
postmitotic neurons; it is estimated that 9 billion mole-
cules of opsin are synthesized each second by approxi-
mately 120 million photoreceptors in the human retina.23
Diurnal shedding and regeneration of membrane discs in
the photoreceptors require stringent control of protein
synthesis and transport.24,25 Mutations in a variety of
genes of varying function are associated with retinal
degeneration. Several RP genes, such as rhodopsin (MIM
180380), RP1 (MIM 603937), CRX (MIM 602225), and
NRL (MIM 162080), are expressed primarily in the
retina.26–30 However, many other retinopathy-associatederican Journal of Human Genetics 84, 792–800, June 12, 2009 797
genes (e.g., RPGR [MIM 312610], CEP290 [MIM 610142],
TOPORS [MIM 609507], PRPF3 [MIM 607301], PRPF8
[MIM 607300], and PRPF31 [MIM 606419]) are more
broadly expressed.31–36 Here, we identify a retinal-disease
gene and suggest an additional cellular mechanism impor-
tant for photoreceptor function and survival.
KLHL7 transcripts arewidely expressed anddetected even
inmature oocytes and embryonic stem cells.37 KLHL7 anti-
bodies have been detected in Sjo¨gren’s syndrome and
in cancer.38,39 Although the physiological function of
KLHL7 is not known, some clues may be derived from the
published research on BTB family proteins that are associ-
ated with the ubiquitin-proteasome pathway of protein
degradation.21 BTB-Kelch family members, KLHL9 (MIM
611201) and KLHL13 (MIM 300655), are part of Cullin-
based E3 ligase complexes involved in cell-cycle progres-
sion,40 whereas KLHL12 is present in another Cullin-based
E3 ligase complex, which targets the dopamine D4 receptor
Figure 3. Expression Analysis and Protein Localization of
KLHL7
(A) Klhl7 RT-PCR product was observed in cDNA from various tissues
(as indicated) and GFP-tagged flow-sorted rod photoreceptors (FS
PR1 and FS PR2).
(B) Immunoblot analysis of KLHL7. A protein of approximately
75 kDa was observed in mouse retina with the use of an a-KLHL7
antibody. Predicted molecular mass of KLHL7 is ~65 kDa.
(C) Immunohistochemical characterization of KLHL7 protein.Mouse
retina was incubated with secondary antibody only (left panel) or
witha-KLHL7 (right panel). KLHL7 staining (green) is strong around
the nuclei in the ganglion cell and the inner nuclear layer.
(D) Immunocytochemistry of a mouse rod photoreceptor. GFP-
tagged photoreceptors were dissociated from Nrl-GFP mouse retina
and incubated with an a-KLHL7 antibody. Weak KLHL7 staining
(red) is detected around the nuclei (DAPI blue) of photoreceptors.798 The American Journal of Human Genetics 84, 792–800, June 12,for ubiquitination.41 The signiﬁcance of protein-degrada-
tion pathways in neuronal development and function is
underscored by the fact that protein aggregates are hall-
marks of several neurodegenerative diseases.42,43 Notably,
mutations in another BTB-Kelch protein family member,
gigaxonin (GAN [MIM 605379]), are responsible for giant
axonal neuropathy.44,45 Interestingly, the p.R138H muta-
tion in gigaxonin44 is at the same position in the BACK
domain as p.S150 is in KLHL7, suggesting its critical role
in mediating protein function.
Our discovery of three disease-causing KLHL7mutations
conﬁned to the BACK domain and resulting speciﬁcally in
dominant retinal degeneration suggests a key biological
role for KLHL7 in cellular pathways. We postulate that
KLHL7 functions in the ubiquitin-proteasome pathway
and that mutations in its BACK domain affect the ability
of KLHL7 to act as an intermediary or chaperone between
an E3 ligase and its substrate. Failure to efﬁciently ubiqui-
tinate a target substrate could then result in accumulation
of the substrate(s) or aggregates, leading to cellular toxicity
within the highly metabolically active photoreceptors. It is
possible that mutations in other KLHL7 domains lead to
a more severe phenotype or even lethality. Additional
investigations are necessary for testing of this hypothesis.
In summary, the identiﬁcation of KLHL7 as an adRP gene
introduces new facets for elucidating retinal biology and
neurodegeneration.
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The URLs for data presented herein are as follows:
DeepView (v4.0.1), http://www.expasy.org/spdbv/
Entrez, http://www.ncbi.nlm.nih.gov2009
Figure 4. KLHL7 Protein Structure and
Analysis
(A) Schematic of KLHL7 isoform 1. Muta-
tions, reported here, are indicated.
(B) Protein alignment of the KLHL7 BACK
domain to Kbtbd4. Mutant residues S150
and A153 are shown in bold and marked
with an asterisk.
(C) Helical model of the KLHL7 BACK
domain. S150 and A153 side chains are
purple and green, respectively. Mutations
150N, 153T, and 153V are red, blue, and
yellow, respectively. Each mutant side
chain appears to occupy more space than
the respective wild-type side chain in the
cleft between two helices.
(D) Superimposition of a1 and a2 helices
of the KLHL7 BACK domain on the Skp1
complex. The a1 and a2 helices of the
KLHL7 BACK domain are structurally similar
(RMSD ¼ 0.84A˚) to the a5 and a6 helices
of Skp1 (inset). Green indicates Skp1.
White is used to show an overlay of the
BACK-domain a1 and a2 to a5 and a6
helices of Skp1. Red indicates the F box.
Yellow indicates the helical linker. Blue
indicates the WD40 domain. PDB:1nex.Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.
nlm.nih.gov/Omim/
POV-Ray, http://povray.org
RetNet, http://www.sph.uth.tmc.edu/Retnet/
Swiss Model, http://swissmodel.expasy.org
WHAT IF, http://swift.cmbi.ru.nl
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